-
Rotigotine Transdermal Patch
- indication:Investigated for use/treatment in neurologic disorders and parkinson's disease.
- pharmacologypharmacology:
- mechanism: Rotigotine, a member of the dopamine agonist class of drugs, is delivered continuously through the skin (transdermal) using a silicone-based patch that is replaced every 24 hours. A dopamine agonist works by activating dopamine receptors in the body, mimicking the effect of the neurotransmitter dopamine.
- toxicity:
- absorprion:
- halflife: 6.82 hours after patch removal at 24 hours
- roouteelimination:
- volumedistribution:
- clearance: